Nasdaq

EDAP TMS SA Announces First Patient Treatment in PULS Trial for Innovative HIFU Therapy Targeting Pancreatic Tumors

EDAP TMS SA announced the successful treatment of the first patient in its phase I/II PULS Trial, which is investigating the use of High Intensity Focused Ultrasound (HIFU) technology for pancreatic ...
Seeking Alpha

EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology

AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored ...
Seeking Alpha

EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)

LYON, France, October 1, 2024 - EDAP TMS SA (EDAP), the global leader in robotic energy-based therapies, today announced that the first patients have been treated in a Phase I/II study evaluating the ...
pix11

EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024)

Semi-Live Focal One Procedure to be Conducted on August 15 t h at 5:00 pm (KST) LYON, France, August 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today ...
Observer-Reporter

St. Clair Hospital offering non-invasive prostate treatment

A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...